Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Studyİrfan ÇİÇİNa, Aydın ÇİLTAŞb, Saadettin KILIÇKAPc, Berna ÖKSÜZOĞLUd, Doğan UNCUe, Mehmet ARTAÇf, Havva YEŞİL ÇINKIRg, Abdurrahman IŞIKDOĞANh, Faysal DANEi, Mehmet ALİUSTAOĞLUj, Hacı Mehmet TÜRKk, Emin Tamer ELKIRANl, Erdem ÇUBUKÇUm, Meltem EKENELn, Feyyaz ÖZDEMİRo, Ali GÖKYERa, İlhan ÖZTOPp, Ahmet ALACACIOĞLUr, Hüseyin ÖZTÜRKs, Birkan AVERs, Metin ÖZKANtaTrakya University Faculty of Medicine, Department of Internal Medicine, Division of Oncology, Edirne, TURKEY
bGazi University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Ankara, TURKEY
cHacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Ankara, TURKEY
dDr. Abdurrahman Yurtarslan Ankara Oncology Training and Research Hospital, Department of Internal Medicine,
Division of Medical Oncology, Ankara, TURKEY
eUniversiy of Health Sciences Ankara Numune Training and Research Hospital, Clinic of Medical Oncology, Ankara, TURKEY
fNecmettin Erbakan University Meram Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Konya, TURKEY
gGaziantep University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Gaziantep, TURKEY
hDicle University Faculty of Medicine, Department of Internal Medicine, Division of Medical Oncology, Diyarbakır, TURKEY
iMarmara University Pendik Training and Research Hospital, Department of Internal Medicine, Division of Medical Oncology, İstanbul, TURKEY
jKartal Dr. Lütfi Kirdar Training and Research Hospital, Department of Medical Oncology, İstanbul, TURKEY
kBezmialem Vakıf University Faculty of Medicine, Department of Medical Oncology, İstanbul, TURKEY
lİnönü University Turgut Ozal Medical Center, Department of Internal Medicine, Division of Medical Oncology, Malatya, TURKEY
mAli Osman Sönmez Oncology Hospital, Department of Medical Oncology, Bursa, TURKEY
nIstanbul University Istanbul Medical Faculty, Department of Medical Oncology, İstanbul, TURKEY
oKaradeniz Technical University Faculty of Medicine, Department of Internal Medicine, Trabzon, TURKEY
pDokuz Eylül University Faculty of Medicine, Department of Medical Oncology, İzmir, TURKEY
rIzmir Katip Çelebi University Atatürk Training and Research Hospital, Department of Medical Oncology, İzmir, TURKEY
sPfizer Pharmaceuticals, Medical Oncology Department, İstanbul, TURKEY
tErciyes University Faculty of Medicine, Department of Internal Medicine, Kayseri, TURKEYDOI: 10.37047/jos.2020-75080 Sayfalar: 87 - 95 2346 Viewed.
JOURNAL of
EN